During the American College of Cardiology's 72nd Annual Scientific Session, “ACC Together with WCC,” five keynote presentations will feature premier experts covering issues facing all who deliver cardiovascular health care today. ACC.23/WCC will take place March 4-6 in New Orleans, LA.
News | ACC
Keynote Speakers to Address Timely Issues at ACC.23

February 22, 2023 — A range of hot topics will be the focus of five ACC23.WCC keynote presentations to be delivered ...

Home February 22, 2023
Home
First U.S. study to show lower risk in patients following SARS-CoV-2 infection
News | Coronavirus (COVID-19)
COVID-19 Vaccination Linked to Fewer Cardiac Events

February 21, 2023 — Analyzing the most extensive datasets in the United States, researchers from the Icahn School of ...

Home February 21, 2023
Home
A research analysis of individuals who had experienced strokes showed greater cerebral blood flow regulation during afternoon hours compared to morning and night times
News | Stroke
Daily Rhythm Detected for Cerebral Blood Flow in Stroke Patients

February 21, 2023 — Strokes are a leading cause of morbidity and mortality in the United States, as well as around the ...

Home February 21, 2023
Home
Screen Shot 2023-02-21 at 10.10.53 AM_0
News | Wearables
AliveCor Announces the ITC’s Limited Exclusion Order Against Apple Clears Presidential Review

February 21, 2023 — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today ...

Home February 21, 2023
Home
NEXLETOL (bempedoic acid) is the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint –
News | Cardiovascular Clinical Studies
Esperion Announces Positive CLEAR Outcomes Results To Be Presented as Late-Breaking Clinical Trial at ACC.23/WCC

February 20, 2023 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...

Home February 20, 2023
Home
A novel preclinical model of ischemic stroke suggests uric acid improves functional outcomes
News | Stroke
SPAN Results, Monitoring Ischemic Stroke in Small- and Large-vessel Disease and Positive Neuroprotective Effects from Aptamer

February 20, 2023 — A novel Stroke Preclinical Assessment Network (SPAN) identified potential neuroprotective effects ...

Home February 20, 2023
Home
Keith Lowry, 68, of Dunbar, Pa is recovering well from the procedure.
News | Artificial Heart
Allegheny Health Network Cardiovascular Institute Completes 500th Heart Transplant

February 17, 2023 — Allegheny Health Network’s (AHN) Cardiovascular Institute reached a significant milestone in cardiac ...

Home February 17, 2023
Home
Jon A. Kobashigawa, MD
News | Cardiovascular Business
Renowned Cardiologist Honored for Medical Contributions in Heart Transplantation

February 17, 2023 — Internationally recognized cardiologist in heart transplantation Jon Kobashigawa, MD, director of ...

Home February 17, 2023
Home
Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScan defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.
News | Implantable Cardioverter Defibrillator (ICD)
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms

February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...

Home February 17, 2023
Home
The American College of Cardiology (ACC) has announced five Late-Breaking Clinical Trial Sessions, two Late-Breaking Clinical Trial Deep Dive Sessions, and three Featured Clinical Research sessions to be presented during its annual scientific session, “ACC with WCC,” or ACC.23/WCC to be held March 4-6 in New Orleans, LA.
Feature | ACC | Christine Book
Late-breaking Clinical Trials, Featured Clinical Research Sessions Announced for American College of Cardiology ACC.23/WCC

February 16, 2023 — The American College of Cardiology (ACC) has announced five Late-Breaking Clinical Trial Sessions ...

Home February 16, 2023
Home
Noise-induced stress causes the release of stress hormones that trigger an inflammatory response, leading to more severe myocardial infarction, oxidative stress and endothelial dysfunction, and subsequent heart failure.
News | Cardiovascular Clinical Studies
Aircraft Noise Increases Damage from Myocardial Infarction

February 16, 2023 — Traffic noise may play an essential role in the development and deterioration of ischemic heart ...

Home February 16, 2023
Home
Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters, announced this week it has received FDA 510(k) clearance for reprocessing the Philips IVUS Eagle Eye Platinum RX Digital catheter.
News | Intra-Vascular Ultrasound (IVUS)
Northeast Scientific Inc. awarded 510(k) clearance to reprocess the Eagle Eye Platinum RX Digital IVUS Catheter

February 16, 2023 — Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters ...

Home February 16, 2023
Home
Acute ischemic stroke patients with each PIRI score on 5-point scale
News | Stroke
Percent Insular Ribbon Infarction for Growth Rate Prediction, Outcomes in Large-Vessel Occlusive Stroke

February 16, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) ...

Home February 16, 2023
Home
The American College of Cardiology (ACC) will be joining with the World Heart Federation (WHF), in conjunction with the World Congress of Cardiology (WCC) for “ACC.23 Together with WCC,” to be held in New Orleans, LA, March 4 – 6, 2023. Program highlights for ACC.23/WCC are offered by the ITN team in this first of a multi-segment overview. Logo image courtesy of ACC.
Feature | ACC | Christine Book
American College of Cardiology Announces “ACC.23 Together with WCC” Program Highlights

February 15, 2023 — The American College of Cardiology (ACC) will be joining with the World Heart Federation (WHF), in ...

Home February 15, 2023
Home
Abbott and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
News | Atherectomy Devices
Abbott to Acquire Cardiovascular Systems, Inc.

February 15, 2023 — Abbott and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott to ...

Home February 15, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now